[1] |
JIANG Yuan, WANG Xiaoyan, LEI lei, LIU Lihua, WU Danfeng, ZHANG Siqi, TANG Dairong, FAN Lingli, FENG Gang, XUE Xiaojing.
Summary of the best evidence for blood glucose management in cancer patients with immune checkpoint inhibitors inducing hyperglycemia
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 722-728.
|
[2] |
HUANG Shihuan, LAN Huiyu, NONG Xiaolian, LI Fanrong, ZHAO Fengjuan, YOU Xuemei.
Network analysis of concurrent symptoms and core symptom identification in patients with intermediate and advanced hepatocellular carcinoma after surgery
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(6): 729-735.
|
[3] |
LI Shuimei, XU Sujuan, YIN Hai, ZHONG Yanmei, LIU Yingying, LIANG Jingyan.
Machine learning-based analysis of risk factors for postoperative facial paralysis in patients with parotid tumors
[J]. Chinese Journal of Oncology Prevention and Treatment, 2024, 16(4): 481-486.
|
[4] |
GAO Fangfang, CHEN Binjie, TAN Qixing, HUANG Zhen, LU Weifeng, WEI Changyuan.
Analysis of risk factors of prognosis,recurrence and metastasis of breast cancer patients with non-pathologic complete response after neoadjuvant chemotherapy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2023, 15(6): 650-656.
|
[5] |
LI Xiajin, LUO Ningbin, CHEN Miao, SU Danke.
Predictive value of preoperative CT signs combined with α?fetoprotein in early recurrence of solitary hepatocellular carcinoma
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(2): 203-207.
|
[6] |
LIU Fuhong, XUE Song, ZHANG Yongping, HUANG Wenqiu, WANG Jingbo.
Allogeneic hematopoietic stem cell transplantation for T cell acute lymphoblastic leukemia and lymphoma: a clinical report of 50 cases
[J]. Chinese Journal of Oncology Prevention and Treatment, 2022, 14(1): 81-86.
|
[7] |
GUO Dezhen, HUANG Ao, ZHANG Shiyu, CHENG Jianwen, WANG Yupeng, YAN Jiayan, HUANG Xiaowu, FAN Jia, YANG Xinrong, ZHOU Jian.
Feasibility study of short tandem repeat genotyping to identify the origin of ultra?late recurrence of liver cancer after liver transplantation
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(5): 458-463.
|
[8] |
LI Changfeng, WANG Qiang, QU Chengming, LI Xuesong, CAI Ping, ZHANG Leida, MA Kuansheng.
Clinical value of a nomogram based on preoperative Gd-EOB-DTPA-enhanced MRI in predicting post-hepatectomy liver failure after liver tumor resection
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(5): 477-483.
|
[9] |
ZHOU Yongxing, TAN Guanqiao, ZHOU Dawei.
Construction and application of an early recurrence prediction model for pancreatic head cancer after radical pancreaticoduodenectomy
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(5): 523-528.
|
[10] |
REN Weigang, LI Jiahui, LI Tieqiu, TAN Wubin, ZHOU Song.
Expression of KIF20A in T1 high⁃grade bladder cancer and its value in predicting postoperative recurrence
[J]. Chinese Journal of Oncology Prevention and Treatment, 2021, 13(4): 420-424.
|
[11] |
TAO Shicheng, LIU Shiqi, ZHANG Chong, MA Zhen, CHEN Guosheng, HUANG Yingbin, LIU Haifeng, MAI Huaming .
Expression and clinical significance of β1 and β2 adrenergic receptors in oral squamous cell carcinoma tissues
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(6): 669-674.
|
[12] |
CHEN Jigui, ZHAO Chang, CHEN Chao, XU Jun, LI Zhiqiang, ZHANG Mei, ZHOU Qiong.
Total resection of retroperitoneal liposarcoma for recurrent retroperitoneal liposarcoma: 4 cases report and literature review
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(6): 686-690.
|
[13] |
TANG Zhihong, YUAN Du, CHEN Zhiwei, MENG Weida, WU Feixiang, WANG Xiaobo.
Value of the aspartate aminotransferase to lymphocyte ratio in evaluating prognosis of primary liver cancer with portal vein tumor thrombus patients before TACE
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(5): 572-577.
|
[14] |
CHEN Zhiwei, WU Feixiang, CHEN Jie, WANG Xiaobo, TANG Zhihong, MENG Weida, WEI Meng, ZHANG Lianda, MAI Rongyun, WEI Tao, SU Hengfeng, LI Lequn, BAI Tao.
Development and evaluation of a predictive model for primary liver cancer recurrence after radiofrequency ablation
[J]. Chinese Journal of Oncology Prevention and Treatment, 2020, 12(1): 63-69.
|
[15] |
PENG Ning, TAO Yiwen, HENG Songqing, YANG Hong, SHANG Liming, XIAO Kaiyin.
Ultrasound guided fusion virtual CT navigation radiofrequency therapy for high risk sites of primary liver cancer
[J]. Chinese Journal of Oncology Prevention and Treatment, 2019, 11(5): 412-415.
|